Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - As India's commerce and finance ministries wrangle over the viability of capping investments by global pharmaceutical companies into Indian generic firms, the Indian Pharmaceutical Alliance led a new offensive urging the government to tighten investment regulations